Skip to main content
. 2013 Mar 26;98(5):E829–E836. doi: 10.1210/jc.2012-3933

Table 4.

Structural Response at the End of the Follow-Up Based on Mutational Profile of Primary Tumors in Patients With Structurally Identifiable RAIA Distant Metastases

SD/PR PD Total
RAS 1a 15b 16 (45%)
BRAF 3 3 6 (17%)
RET/PTC 3 0 3 (8%)
PIK3CA 0 1 1 (2%)
No mutation 6 4 10 (28%)
Total 13 23 36 (100%)
a

1 NRAS, 0 KRAS.

b

11 NRAS, 2 KRAS, 2 HRAS.